Genetic polymorphism in FOXP3 gene: Imbalance in regulatory T-cell role and development of human diseases

Journal of Genetics

Volumn 92, Issue 1, 2013, Pages 163-171

  Oda, Julie Massayo Maeda ^a   Hirata, Bruna Karina Banin ^a   Guembarovski, Roberta Losi ^a   Watanabe, Maria Angelica Ehara ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

disease; exon region; FOXP3 gene; intron region; mutation; polymorphism; promoter region; Treg cells

Indexed keywords

EID: 84877697517     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-013-0213-7     Document Type: Article

References (78)

1. Andre G. M., Barbosa C. P., Teles J. S., Vilarino F. L., Christofolini D. M. and Bianco B. 2011 Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil. Steril. 95, 2223-7.
2. Anover S., Linane A., Vijay S., Gambineri E., Goulet O., Moes N. et al. 2006 Sa. 97. A unique mutation in an upstream region of the FOXP3 gene causes IPEX by aberrant mRNA splicing and lack of FOXP3+ Treg. Clin. Immunol. 119, S139.
3. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S. E., Perroni L. et al. 2006 Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713-1722.
4. Bafunno V., Santacroce R., Chetta M., D'Andrea G., Pisanelli D., Sessa F. et al. 2010 Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A. Haemophilia16, 469-473.
5. Ban Y., Tozaki T., Tobe T., Jacobson E. M., Concepcion E. S. and Tomer Y. 2007 The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun. 28, 201-207.
6. Bandukwala H. S., Wu Y., Feuerer M., Chen Y., Barboza B., Ghosh S. et al. 2011 Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity34, 479-491.
7. Baron U., Floess S., Wieczorek G., Baumann K., Grutzkau A., Dong J. et al. 2007 DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 37, 2378-2389.
8. Bassuny W. M., Ihara K., Sasaki Y., Kuromaru R., Kohno H., Matsuura N. and Hara T. 2003 A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics55, 149-156.
9. Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L. et al. 2001 The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21.
10. Bettelli E., Dastrange M. and Oukka M. 2005 Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA102, 5138-5143.
11. Betts G. J., Clarke S. L., Richards H. E., Godkin A. J. and Gallimore A. M. 2006 Regulating the immune response to tumours. Adv. Drug Deliv. Rev. 58, 948-961.
12. Bjornvold M., Amundsen S. S., Stene L. C., Joner G., Dahl-Jorgensen K., Njolstad P. R. et al. 2006 FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27, 140-144.
13. Bottema R. W., Kerkhof M., Reijmerink N. E., Koppelman G. H., Thijs C., Stelma F. F. et al. 2010 X- chromosome Forkhead box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts. Allergy65, 865-874.
14. Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A. et al. 2001 Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73.
15. Campbell D. J. and Ziegler S. F. 2007 FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat. Rev. Immunol. 7, 305-310.
16. Chae W. J., Henegariu O., Lee S. K. and Bothwell A. L. 2006 The mutant leucine- zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc. Natl. Acad. Sci. USA103, 9631-9636.
17. Chaudhry A., Rudra D., Treuting P., Samstein R. M., Liang Y., Kas A. and Rudensky A. Y. 2009 CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science326, 986-991.
18. Coffer P. J. and Burgering B. M. 2004 Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4, 889-899.
19. Du J., Huang C., Zhou B. and Ziegler S. F. 2008 Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J. Immunol. 180, 4785-4792.
20. Eastell T., Hinks A. and Thomson W. 2007 SNPs in the FOXP3 gene region show no association with juvenile idiopathic arthritis in a UK Caucasian population. Rheumatology46, 1263-1265.
21. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J. et al. 2007 Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38.
22. Fodor E., Garaczi E., Polyanka H., Koreck A., Kemeny L. and Szell M. 2011 The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Hum. Immunol. 72, 926-929.
23. Fontenot J. D., Rasmussen J. P., Williams L. M., Dooley J. L., Farr A. G. and Rudensky A. Y. 2005 Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity22, 329-341.
24. Gambineri E., Torgerson T. R. and Ochs H. D. 2003 Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430-435.
25. Gao L., Li K., Li F., Li H., Liu L., Wang L. et al. 2010 Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J. Dermatol. Sci. 57, 51-56.
26. Hancock W. W. and Ozkaynak E. 2009 Three distinct domains contribute to nuclear transport of murine Foxp3. PLoS One4, e7890.
27. Hanel S. A., Velavan T. P., Kremsner P. G. and Kun J. F. 2011 Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population. Immunogenetics63, 409-415.
28. Hoogendoorn B., Coleman S. L., Guy C. A., Smith K., Bowen T., Buckland P. R. and O'Donovan M. C. 2003 Functional analysis of human promoter polymorphisms. Hum. Mol. Genet. 12, 2249-2254.
29. Howson J. M., Walker N. M., Smyth D. J. and Todd J. A. 2009 Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun. 10 suppl 1, 74-84.
30. Huehn J., Polansky J. K. and Hamann A. 2009 Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9, 83-89.
31. Inoue N., Watanabe M., Morita M., Tomizawa R., Akamizu T., Tatsumi K. et al. 2010 Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin. Exp. Immunol. 162, 402-406.
32. Jonuleit H. and Schmitt E. 2003 The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171, 6323-6327.
33. Kim H. P. and Leonard W. J. 2007 CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204, 1543-1551.
34. Kim K. H., Kim T. M., Go H., Kim W. Y., Jeon Y. K., Lee S. H. et al. 2011 Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Cancer Sci. 102, 1972-1976.
35. Kitoh A., Ono M., Naoe Y., Ohkura N., Yamaguchi T., Yaguchi H. et al. 2009 Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo- suppressive function of FoxP3+ regulatory T cells. Immunity31, 609-620.
36. Leavy O. 2011 Immune regulation: macrophages join the FOXP3 suppressor gang. Nat. Rev. Immunol. 11, 438.
37. Li B. and Greene M. I. 2007 FOXP3 actively represses transcription by recruiting the HAT/HDAC complex. Cell. Cycle6, 1432-1436.
38. Li B., Samanta A., Song X., Furuuchi K., Iacono K. T., Kennedy S. et al. 2006 FOXP3 ensembles in T-cell regulation. Immunol. Rev. 212, 99-113.
39. Li B., Samanta A., Song X., Iacono K. T., Bembas K., Tao R. et al. 2007a FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA104, 4571-4576.
40. Li B., Samanta A., Song X., Iacono K. T., Brennan P., Chatila T. A. et al. 2007b FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 19, 825-835.
41. Li S., Weidenfeld J. and Morrisey E. E. 2004 Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol. Cell Biol. 24, 809-822.
42. Lin Y. C., Lee J. H., Wu A. S., Tsai C. Y., Yu H. H., Wang L. C. et al. 2011 Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study. Lupus20, 137-143.
43. Liu F., Lang R., Zhao J., Zhang X., Pringle G. A., Fan Y. et al. 2011 CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res. Treat130, 645-655.
44. Lopes J. E., Torgerson T. R., Schubert L. A., Anover S. D., Ocheltree E. L., Ochs H. D. and Ziegler S. F. 2006 Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 177, 3133-3142.
45. Lu H. 2009 FOXP3 expression and prognosis: role of both the tumor and T cells. J. Clin. Oncol. 27, 1735-1736.
46. Mackey-Cushman S. L., Gao J., Holmes D. A., Nunoya J. I., Wang R., Unutmaz D. and Su L. 2011 FoxP3 interacts with linker histone H1. 5 to modulate gene expression and program Treg cell activity. Genes Immun. 12, 559-567.
47. Manrique S. Z., Correa M. A., Hoelzinger D. B., Dominguez A. L., Mirza N., Lin H. H. et al. 2011 Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth. J. Exp. Med. 208, 1485-1499.
48. Mantel P. Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K. and Schmidt-Weber C. B. 2006 Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176, 3593-3602.
49. Marson A., Kretschmer K., Frampton G. M., Jacobsen E. S., Polansky J. K., MacIsaac K. D. et al. 2007 Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature445, 931-935.
50. Nagar M., Vernitsky H., Cohen Y., Dominissini D., Berkun Y., Rechavi G. et al. 2008 Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells. Int. Immunol. 20, 1041-1055.
51. Nakanishi K. and Shima Y. 2007 No contribution of a GT microsatellite polymorphism in the promoter region of the FOXP3 gene to susceptibility to type 1 diabetes in the Japanese population. Clin. Chim. Acta384, 171-173.
52. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T. et al. 2007 Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature446, 685-689.
53. Owen C. J., Eden J. A., Jennings C. E., Wilson V., Cheetham T. D. and Pearce S. H. 2006 Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J. Mol. Endocrinol. 37, 97-104.
54. Park O., Grishina I., Leung P. S., Gershwin M. E. and Prindiville T. 2005 Analysis of the Foxp3/scurfin gene in Crohn's disease. Ann. N. Y. Acad. Sci. 1051, 218-228.
55. Raskin L., Rennert G. and Gruber S. B. 2009 FOXP3 germline polymorphisms are not associated with risk of breast cancer. Cancer Genet. Cytogenet. 190, 40-42.
56. Rudra D., Egawa T., Chong M. M., Treuting P., Littman D. R. and Rudensky A. Y. 2009 Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10, 1170-1177.
57. Sakaguchi S. 2005 Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
58. Sakaguchi S., Yamaguchi T., Nomura T. and Ono M. 2008 Regulatory T cells and immune tolerance. Cell133, 775-787.
59. Sanchez E., Rueda B., Orozco G., Oliver J., Vilchez J. R., Paco L. et al. 2005 Analysis of a GT microsatellite in the promoter of the foxp3/scurfin gene in autoimmune diseases. Hum. Immunol. 66, 869-873.
60. Shen Z., Chen L., Hao F., Wang G. and Liu Y. 2010 Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding. J. Cell. Mol. Med. 14, 226-241.
61. Stroud J. C., Wu Y., Bates D. L., Han A., Nowick K., Paabo S., Tong H. and Chen L. 2006 Structure of the forkhead domain of FOXP2 bound to DNA. Structure14, 159-166.
62. Toker A. and Huehn J. 2011 To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms. Sci. Signal4, e4.
63. Tone M. and Greene M. I. 2011 Cooperative regulatory events and Foxp3 expression. Nat. Immunol. 12, 14-16.
64. Tone Y., Furuuchi K., Kojima Y., Tykocinski M. L., Greene M. I. and Tone M. 2008 Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202.
65. Torgerson T. R. and Ochs H. D. 2007 Regulatory T cells in primary immunodeficiency diseases. Curr. Opin. Allergy Clin. Immunol. 7, 515-521.
66. van der Vliet H. J. and Nieuwenhuis E. E. 2007 IPEX as a result of mutations in FOXP3. Clin. Dev. Immunol. 2007, 89017.
67. Vignali D. A., Collison L. W. and Workman C. J. 2008 How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532.
68. Wang B., Lin D., Li C. and Tucker P. 2003 Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 278, 24259-24268.
69. Watanabe M. A., Oda J. M., Amarante M. K. and Cesar Voltarelli J. 2010 Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis. Rev. 29, 569-579.
70. Wildin R. S., Smyk-Pearson S. and Filipovich A. H. 2002 Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39, 537-545.
71. Williams L. M. and Rudensky A. Y. 2007 Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277-284.
72. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A. D., Stroud J. C. et al. 2006 FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell126, 375-387.
73. Wu Z., You Z., Zhang C., Li Z., Su X., Zhang X. and Li Y. 2012 Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clin. Dev. Immunol. 2012, 896458.
74. Zavattari P., Deidda E., Pitzalis M., Zoa B., Moi L., Lampis R. et al. 2004 No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes53, 1911-1914.
75. Zhang L., Zhang Y., Desrosiers M., Wang C., Zhao Y. and Han D. 2009 Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Hum. Immunol. 70, 930-934.
76. Zheng Y., Josefowicz S. Z., Kas A., Chu T. T., Gavin M. A. and Rudensky A. Y. 2007 Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature445, 936-940.
77. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J. M., Chu T. T. et al. 2009 Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature458, 351-356.
78. Zhou L., Lopes J. E., Chong M. M., Ivanov, I. I., Min R., Victora G. D. et al. 2008 TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature453, 236-240.